FDA GenomeTRAKR Program and Regulatory Implications

Tuesday, August 2, 2016: 3:30 PM
228-229 (America's Center - St. Louis)
Ruth Timme, U.S. Food and Drug Administration, College Park, MD
Introduction:
Purpose:
Methods:
Results:
Significance